Takahashi Ken-ichi, Miyagawa Kikuo, Mitachi Yasushi, Masuda Takayuki, Oogoshi Takahiko
Dept. of Surgery, Sendai Teishin Hospital.
Gan To Kagaku Ryoho. 2003 May;30(5):685-9.
The patient was a 61-year-old man who had gastric cancer with metastasis to cervical lymph nodes and pulmonary lymphangitis carcinomatosa. He received daily oral administration of 120 mg of TS-1 (day 1-21) and systemic administration of 100 mg of CDDP (day 8) as one treatment course. As the metastatic lesions had disappeared after chemotherapy, he underwent total gastrectomy. Histopathological examination of resected regional lymph nodes revealed marked fibrosis and a small amount of scattered cancer cells. Although much peritoneal dissemination was observed macroscopically, histopathological examination of these tumors revealed only fibrosis with no cancer cells. These findings supported the effect of this neoadjuvant chemotherapy. He died of recurrence of the carcinoma 203 days after surgery, without any sign of recurrence of metastasis to cervical lymph nodes or pulmonary lymphangitis carcinomatosa.
该患者为61岁男性,患有胃癌并伴有颈部淋巴结转移及肺淋巴管癌病。他接受了一个疗程的治疗,每天口服120毫克替吉奥(第1 - 21天),并在第8天全身给予100毫克顺铂。由于化疗后转移灶消失,他接受了全胃切除术。对切除的区域淋巴结进行组织病理学检查发现有明显纤维化及少量散在癌细胞。尽管肉眼观察到大量腹膜播散,但对这些肿瘤进行组织病理学检查仅发现纤维化,未见癌细胞。这些结果支持了这种新辅助化疗的效果。他在术后203天死于癌症复发,颈部淋巴结转移或肺淋巴管癌病均无复发迹象。